Steven Cohen’s Exact Sciences EXAS Stock Holding History

Steven Cohen’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,300	Closed	-$437K	–	3995
2025 Q4	$437K	Buy	+4,300	New	+$345K	﹤0.01%	3302
2025 Q1	–	Sell	-583,000	Closed	-$32.8M	–	2183
2024 Q4	$32.8M	Buy	+583,000	New	+$36.3M	0.07%	322
2024 Q2	–	Sell	-170,000	Closed	-$11.7M	–	2021
2024 Q1	$11.7M	Buy	170,000 +130,000	+325%	+$8.22M	0.03%	658
2023 Q4	$2.96M	Buy	+40,000	New	+$2.62M	0.01%	1086
2022 Q4	–	Sell	-25,000	Closed	-$812K	–	1598
2022 Q3	$812K	Buy	+25,000	New	+$1.03M	﹤0.01%	1093

Other funds holding EXAS

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Steven Cohen's EXAS Position: Q1 2026 in Review

Steven Cohen sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 180,575 shares — an estimated $18.3M sold.

Steven Cohen first reported a position in EXAS in Q3 2014 and held it in 29 quarters. The position peaked at $136M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Steven Cohen reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Steven Cohen sold 180,575 Exact Sciences shares in Q1 2026, an estimated $18.3M.
Steven Cohen first reported a position in Exact Sciences in Q3 2014 and held it in 29 quarters.
Steven Cohen's Exact Sciences position peaked at $136M in Q1 2024.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.